Renin–angiotensin–aldosterone system has a pivotal role in cognitive impairment
Authors:
- 23 May 2013
- journal article
- review article
- Published by Springer Nature in Hypertension Research
- Vol. 36 (9) , 753-758
Abstract
Because dementia is associated with both deterioration in the quality of life and poor prognosis, the prevention of cognitive impairment (CI) is a critical problem in public health promotion. Hypertension is a risk factor for the aggravation of CI, and the renin–angiotensin–aldosterone system (RAAS) is a key player in the increased incidence and development of hypertension. Therefore, the RAAS is considered to be a promoting factor for CI development. Conversely, recent studies have shown that lowering blood pressure with RAAS inhibitors decreases the incidence of CI, dementia and cardiovascular disease. Blood–brain barrier-penetrating RAAS inhibitors appear to have advantages in preventing cognitive decline because they can suppress the RAAS in the hippocampus, which has an important role in cognition. Thus, RAAS blockage is a notable strategy for preventing CI.Keywords
This publication has 91 references indexed in Scilit:
- Impact of Angiotensin Receptor Blockers on Alzheimer Disease Neuropathology in a Large Brain Autopsy SeriesArchives of Neurology, 2012
- Cognitive impairment and risk of cardiovascular events and mortalityEuropean Heart Journal, 2012
- Peroxisome Proliferator-Activated Receptor-γ Activation With Angiotensin II Type 1 Receptor Blockade Is Pivotal for the Prevention of Blood-Brain Barrier Impairment and Cognitive Decline in Type 2 Diabetic MiceHypertension, 2012
- Direct Stimulation of Angiotensin II Type 2 Receptor Enhances Spatial MemoryJournal of Cerebral Blood Flow & Metabolism, 2011
- Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With HypertensionArchives of internal medicine (1960), 2009
- Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trialThe Lancet Neurology, 2008
- High Blood Pressure, Hypertension, and High Pulse Pressure Are Associated with Poorer Cognitive Function in Persons Aged 60 and Older: The Third National Health and Nutrition Examination SurveyJournal of the American Geriatrics Society, 2008
- Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer diseaseJournal of Clinical Investigation, 2007
- The CNS renin-angiotensin systemCell and tissue research, 2006
- 15-year longitudinal study of blood pressure and dementiaThe Lancet, 1996